TALS Research and Charts

TALS - Talaris Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-09-12)

Last 47.61	Change ⇑ +0.01 (+0.02%)	Volume 986,164
	Open 47.62	High 47.70	Low 47.59

8EMA (Daily) 39.63	40EMA (Daily) 26.86	50EMA (Daily) 25.50	STO (Daily) 98.866	MACD Hist (Daily) 5.375
8EMA (Weekly) 28.092	40EMA (Weekly) 20.57	50EMA (Weekly) 20.11	STO (Weekly) 90.612	MACD Hist (Weekly) 4.831


Company Profile
Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.